BA vs IMA · P/E 89, rev $89.46B vs rev $9.2M
The Boeing Company (BA) versus ImageneBio, Inc. (IMA) — a side-by-side from cached financials, not a winner call.
The Boeing Company (BA) is a aerospace & defense company listed on NYSE. It is led by Kelly Ortberg.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Latest reported BA revenue for 2025-12-31 was $89.46B. Net income was $2.23B. Revenue was up 34.5% from 2024-12-31 to 2025-12-31. BA currently screens at market cap $177.86B and trailing P/E 89.2.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
BA currently screens at market cap $177.86B and trailing P/E 89.2. IMA currently screens at market cap $64.7M.
Not investment advice. Open the BA and IMA stock pages for the full models.
Not investment advice.